Sort
78,016 grants matching “breast cancer”
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
$597,280Linda K Larkey · Arizona State University-Tempe Campus · R01 · FY2017 · CA
P53, DNA Repair Imbalance, and Immune Response in Breast Cancer Mortality Disparities
$597,226Melissa A. Troester · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Optimizing psychosocial intervention for breast cancer-related sexual morbidity: A factorial trial using the National Cancer Institute Community Oncology Research Program (NCORP) network
$597,222Kelly McLean Shaffer · University Of Virginia · R37 · FY2025 · CA
Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment Response
$597,211David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2019 · CA
A Search for Small Molecule Inhibitors of the Hypoxia Response Pathway
$597,204Kevin H Gardner · Ut Southwestern Medical Center · P01 · FY2007 · CA
Tumor selective inhibition of the WNT pathway
$597,189Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Targeting B7-H3 in ovarian cancer
$597,170Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
The non-catalytic function of PARP2 in DNA repair and cancer therapy
$597,140Shan Zha · Columbia University Health Sciences · R01 · FY2022 · CA
Early Detection and Diagnosis of Lung Cancer with Endomicroscopy
$597,127Melissa J Suter · Massachusetts General Hospital · R01 · FY2024 · CA
NRF2 suppression of inflammatory signaling and its role in tumor progression
$597,119James V Alvarez · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
EPIDEMIOLOGY OF CANCER IN A COHORT OF OLDER WOMEN
$597,118University Of Minnesota Twin Cities · R01 · FY2002 · CA
Understanding affective processing of scientific evidence to promote informed choice for breast cancer screening
$597,097Laura D. Scherer · University Of Colorado Denver · R37 · FY2024 · CA
Taking AIM at Breast Cancer: Targeting Adiposity and Inflammation with Movement to Improve Prognosis in Breast Cancer Survivors
$597,065Christina Dieli-Conwright · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer
$597,064Carol Ann Lange · University Of Minnesota · R01 · FY2021 · CA
Three-Arm randomized trial comparing the effect of aspirin, sulindac or no treatment control on breast density in patients with elevated breast cancer risk
$597,059Patricia Ann Thompson-Carino · State University New York Stony Brook · R01 · FY2024 · CA
Developmental Core- Pilot Projects, Full Projects, Biostat Core and Outreach Prog
$597,025Raymond Nelson Dubois · University Of Tx Md Anderson Can Ctr · U54 · FY2008 · CA
Multi-site adaptive trial of a technology-based, EHR-integrated physical activity intervention in breast and endometrial cancer survivors
$596,996Siobhan Marie Phillips · Northwestern University At Chicago · R37 · FY2024 · CA
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$596,948Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2025 · CA
Multilevel Resilience Trajectories in the Transition to Cancer Survivorship
$596,896Crystal L Park · University Of Connecticut Storrs · UH3 · FY2021 · CA
Metabolic Targets in Pten-Tumors
$596,888Jeffrey A Smith · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2010 · CA
Preventing adaptive drug resistance through Mediator kinase inhibition
$596,858Igor B Roninson · University Of South Carolina At Columbia · R01 · FY2023 · CA
Hematopathology Fellowship
$596,786Elaine Jaffe · Division Of Basic Sciences - Nci · ZIE · FY2015 · CA
Optimizing prognostic and predictive algorithms using residual disease (RD) genomic biomarkers in HER2+ and TNBC
$596,748Lisa A Carey · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
Combined Methylation and Mutation to Predict Response to PARP Inhibitors
$596,715Elizabeth Mary Swisher · University Of Washington · R01 · FY2022 · CA
Notch in Angiogenesis and Vascular Biology
$596,676Jan K. Kitajewski · University Of Illinois At Chicago · R01 · FY2024 · HL